Blue Trust’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$171K Sell
889
-233
-21% -$25.1K ﹤0.01% 819
2026
Q2
$78.6K Sell
1,122
-165
-13% -$8.54K ﹤0.01% 1145
2026
Q1
$65.4K Sell
1,287
-168
-12% -$7.84K ﹤0.01% 1217
2025
Q4
$42.9K Sell
1,455
-54
-4% -$1.47K ﹤0.01% 1412
2025
Q3
$39K Sell
1,509
-1,283
-46% -$35.8K ﹤0.01% 1493
2025
Q2
$77K Buy
2,792
+1,112
+66% +$29.3K ﹤0.01% 1162
2025
Q1
$47.6K Sell
1,680
-75
-4% -$2.66K ﹤0.01% 1388
2024
Q4
$73K Buy
1,755
+1,024
+140% +$48.9K ﹤0.01% 1072
2024
Q3
$86.8K Buy
731
+574
+366% +$52.7K ﹤0.01% 1293
2024
Q2
$16.7K Buy
157
+77
+96% +$9.7K ﹤0.01% 1739
2024
Q1
$8.52K Buy
80
+10
+14% +$1.01K ﹤0.01% 1491
2023
Q4
$8K Sell
70
-38
-35% -$3.2K ﹤0.01% 1666
2023
Q3
$13K Buy
108
+43
+66% +$4.8K ﹤0.01% 1327
2023
Q2
$10K Sell
65
-655
-91% -$87.4K ﹤0.01% 1309
2023
Q1
$129K Buy
720
+500
+227% +$82.5K ﹤0.01% 687
2022
Q4
$26K Buy
220
+166
+307% +$27.1K ﹤0.01% 1193
2022
Q3
$7K Sell
54
-15
-22% -$2.28K ﹤0.01% 1472
2022
Q2
$12K Buy
+69
New +$9.9K ﹤0.01% 1147

Other funds holding MRNA

Blue Trust's MRNA Position: Q3 2026 in Review

Blue Trust reduced its Moderna (MRNA) stake by 21% in Q3 2026, selling an estimated $25.1K and leaving 889 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Blue Trust first reported a position in MRNA in Q2 2022 and has held it in 18 quarters since. 877 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Blue Trust held 889 shares of Moderna worth $171K as of Q3 2026.
  • Blue Trust sold 233 Moderna shares in Q3 2026, an estimated $25.1K.
  • Moderna made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #819 holding.
  • Blue Trust first reported a position in Moderna in Q2 2022 and has held it in 18 quarters since.
  • 877 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.